# Chronic Obstructive Pulmonary Disease: Use of the St George’s Respiratory Questionnaire as a PRO Assessment Tool Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/chronic-obstructive-pulmonary-disease-use-of-the-st-georges-respiratory-questionnaire-as-a-pro-assessment-tool-guidance-for-industry/4027ee92-8cfb-4ad2-8e77-14364c6dafdb

> FDA guidance document: Chronic Obstructive Pulmonary Disease: Use of the St George’s Respiratory Questionnaire as a PRO Assessment Tool Guidance for Industry. Issue date: March 26, 2018. Get complete insights and analysis.

---

## Details

- Title: Chronic Obstructive Pulmonary Disease: Use of the St George’s Respiratory Questionnaire as a PRO Assessment Tool Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-03-26
- Last Changed: 2020-05-04
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2017-D-6821">FDA-2017-D-6821</a>

## Related Documents

- [Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f)
- [Nonallergic Rhinitis:  Developing Drug Products for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/nonallergic-rhinitis-developing-drug-products-for-treatment/5453a88f-6b6b-4771-8248-e324727993ad)
- [Migraine: Developing Drugs for Acute Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-acute-treatment/39ba4b4b-6c93-4849-a087-866c6bf4edff)